Vaso-Occlusive Pain Management in a Patient With Sickle Cell Disease Associated With Moyamoya Syndrome

Cureus. 2022 Mar 30;14(3):e23667. doi: 10.7759/cureus.23667. eCollection 2022 Mar.

Abstract

Moyamoya syndrome in a sickle cell disease patient may be a difficult task to manage in the setting of a vaso-occlusive pain crisis. Maintaining stable blood pressure is necessary to prevent stroke as both hypertension and hypotension can be detrimental to the patient, leading to hemorrhagic and ischemic stroke, respectively. Opioid management for pain control in such patients must be taken into consideration. Because every patient is unique, opioid regimens should be optimized to relieve patients' specific pain while also practicing non-maleficence in preventing hypotension and strokes.

Keywords: hypotension; moyamoya syndrome; pain management; sickle cell disease; vaso-occlusive pain.

Publication types

  • Case Reports